Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Michel

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 13, 2023
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapyElias Haj-Yehia, Raluca I Mincu, Sebastian Korste, et al.
ESC Heart Failure|July 27, 2022
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyJulia Pohl, Matthias Totzeck, Raluca-I Mincu, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
International Journal of Cardiology. Heart & Vasculature|January 30, 2025
Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy - A real-world observational studyTobias Lerchner, Raluca I Mincu, Florian Bühning, et al.
Thyroid : Official Journal of the American Thyroid Association|June 26, 2019
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone ReceptorSvenja Plöhn, Matthias Hose, Anke Schlüter, et al.
International Journal of Molecular Sciences|April 13, 2023
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the HeartSebastian Korste, Stephan Settelmeier, Lars Michel, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
JACC. Advances|July 17, 2025
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac AmyloidosisJulia Vogel, Peter Luedike, Katharina Hellhammer, et al.
JACC. Cardiovascular Imaging|May 31, 2024
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice: A Pictorial Imaging VignetteStephan Settelmeier, Lukas Kessler, Zohreh Varasteh, et al.
Annals of Nuclear Medicine|April 16, 2026
Semi-quantitative evaluation of early phase <sup>99m</sup>Tc-DPD scintigraphy in patients with suspected cardiac amyloidosisLukas Kessler, Leon Ferber, Christoph Rischpler, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 13, 2023
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapyElias Haj-Yehia, Raluca I Mincu, Sebastian Korste, et al.
ESC Heart Failure|July 27, 2022
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyJulia Pohl, Matthias Totzeck, Raluca-I Mincu, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
International Journal of Cardiology. Heart & Vasculature|January 30, 2025
Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy - A real-world observational studyTobias Lerchner, Raluca I Mincu, Florian Bühning, et al.
Thyroid : Official Journal of the American Thyroid Association|June 26, 2019
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone ReceptorSvenja Plöhn, Matthias Hose, Anke Schlüter, et al.
International Journal of Molecular Sciences|April 13, 2023
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the HeartSebastian Korste, Stephan Settelmeier, Lars Michel, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
JACC. Advances|July 17, 2025
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac AmyloidosisJulia Vogel, Peter Luedike, Katharina Hellhammer, et al.
JACC. Cardiovascular Imaging|May 31, 2024
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice: A Pictorial Imaging VignetteStephan Settelmeier, Lukas Kessler, Zohreh Varasteh, et al.
Annals of Nuclear Medicine|April 16, 2026
Semi-quantitative evaluation of early phase <sup>99m</sup>Tc-DPD scintigraphy in patients with suspected cardiac amyloidosisLukas Kessler, Leon Ferber, Christoph Rischpler, et al.
Pageof 7